Mdxhealth Sa Adr Stock Annual Yield
MDXH Stock | USD 1.96 0.02 1.03% |
MDxHealth SA ADR fundamentals help investors to digest information that contributes to MDxHealth's financial success or failures. It also enables traders to predict the movement of MDxHealth Stock. The fundamental analysis module provides a way to measure MDxHealth's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MDxHealth stock.
MDxHealth | Annual Yield |
MDxHealth SA ADR Company Annual Yield Analysis
MDxHealth's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
MDxHealth Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for MDxHealth is extremely important. It helps to project a fair market value of MDxHealth Stock properly, considering its historical fundamentals such as Annual Yield. Since MDxHealth's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MDxHealth's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MDxHealth's interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, MDxHealth SA ADR has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
All Next | Launch Module |
MDxHealth Fundamentals
Return On Equity | -2.41 | ||||
Return On Asset | -0.11 | ||||
Profit Margin | (0.50) % | ||||
Operating Margin | (0.26) % | ||||
Current Valuation | 102.09 M | ||||
Shares Outstanding | 49.5 M | ||||
Shares Owned By Insiders | 12.20 % | ||||
Shares Owned By Institutions | 48.65 % | ||||
Number Of Shares Shorted | 14.24 K | ||||
Price To Book | 5.65 X | ||||
Price To Sales | 1.13 X | ||||
Revenue | 70.19 M | ||||
Gross Profit | 19.22 M | ||||
EBITDA | (30.47 M) | ||||
Net Income | (43.1 M) | ||||
Cash And Equivalents | 40.02 M | ||||
Cash Per Share | 2.57 X | ||||
Total Debt | 41.27 M | ||||
Debt To Equity | 0.48 % | ||||
Current Ratio | 2.38 X | ||||
Book Value Per Share | 0.61 X | ||||
Cash Flow From Operations | (21.5 M) | ||||
Short Ratio | 0.15 X | ||||
Earnings Per Share | (1.53) X | ||||
Target Price | 6.04 | ||||
Number Of Employees | 300 | ||||
Beta | -393983.0 | ||||
Market Capitalization | 96.02 M | ||||
Total Asset | 129.13 M | ||||
Retained Earnings | (331.45 M) | ||||
Working Capital | 18.64 M | ||||
Net Asset | 129.13 M |
About MDxHealth Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MDxHealth SA ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MDxHealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MDxHealth SA ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:Check out MDxHealth Piotroski F Score and MDxHealth Altman Z Score analysis. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MDxHealth. If investors know MDxHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 3.099 | Quarterly Revenue Growth 0.205 | Return On Assets (0.11) | Return On Equity (2.41) |
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MDxHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if MDxHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MDxHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.